Ambady, P
Wu, Y J
Walker, J M
Kersch, C
Pagel, M A
Woltjer, R L
Fu, R
Muldoon, L L
Neuwelt, E A
Article History
Received: 4 May 2017
Accepted: 20 May 2017
First Online: 28 July 2017
Competing interests
: A provisional US patent application (#62/378,780), entitled ‘Morpholino oligonucleotides useful in cancer treatment’ was submitted to US patent office by the authors PA, YJW and EAN. The other authors declare no conflict of interest.